Merck & Co. v. Teva Pharmaceuticals (Fed. Cir. 2005) (on petition for rehearing). Merck & Co. owns the patent on the best-selling drug Fosamax.  Teva, a generic manufacturer lost an infringement case at the district court after the court found the patent valid and infringed.  In January 2005, the Court of Appeals for the Federal … Continue reading Full Panel Denies Rehearing in Fosamax Patent Case